PG-SGA评分与胃癌患者病理分期的相关性研究
The Correlation Study of PG-SGA and Pathological Stage of Patients with Gastric Cancer
DOI: 10.12677/WJCR.2021.112008, PDF,    科研立项经费支持
作者: 王昌利, 吴向华*, 张江涛, 黄道来, 陈俊强, 贾 葵, 陆利生:广西医科大学第一附属医院,胃肠腺体外科,广西 南宁;张勇胜:广西医科大学第一附属医院,营养科,广西 南宁;王献满:广西医科大学第一附属医院,心血管内科,广西 南宁
关键词: 胃癌PG-SGA白蛋白BMI病理分期Gastric Cancer PG-SGA Albumin BMI Pathological Staging
摘要: 目的:研究患者病理分期、血浆白蛋白、年龄、脉管浸润、肿瘤大小、BMI与胃癌患者主观整体评估(PG-SGA)评分的相关性。探讨胃癌患者病理分期对营养不良风险严重程度的影响。方法:采用连续入组法,纳入我院自2019年8月至2020年8月接受外科手术的248例胃癌患者,入院24小时运用PG-SGA对患者进行营养风险状态评估,并测定患者白蛋白(Alb)、身体质量指数(BMI),并收集患者的病理报告内容。结果:营养不良风险严重程度在患者脉管浸润、病理分期、年龄、白蛋白、肿瘤大小、BMI有统计学意义p < 0.05。在民族、性别上无统计学意义p > 0.05。筛查出来的影响因素,行logistic回归分析研究。1、BMI是胃癌患者营养不良风险严重程度的独立保护因素,BMI越高,营养不良风险程度越低。2、血浆白蛋白是营养不良风险严重程度的独立保护因素,血浆白蛋白越高,营养不良风险程度越低。3、年龄越高出现的营养不良风险严重程度越高。4、病理分期是营养不良风险程度的独立影响因素,病理分期越高出现的营养不良风险严重程度越高。5、脉管浸润、肿瘤大小不是营养不良风险严重程度的独立影响因素p > 0.05。结论:1、血浆白蛋白、BMI是营养不良风险严重程度的独立保护因素。2、年龄是胃癌患者营养不良风险严重程度的独立危险因素。3、胃癌患者的病理分期越高,患者的营养不良风险越严重,病理分期是营养不良风险严重程度的独立危险因素。
Abstract: Objective: To study the correlation between patients’ pathological stage, plasma albumin (Alb), (body mass index) BMI, age, tumor size, vascular infiltration and PG-SGA score of gastric cancer patients; To explore the influence of pathological staging on the severity of malnutrition risk. Methods: 248 patients with gastric cancer who underwent surgical operations in our hospital from August 2019 to August 2020 were enrolled using consecutive sampling in this study. After 24 hours of admission, PG-SGA were used to evaluate the nutritional status of the patient, and to measure the Alb, BMI and collect the content of the patient’s pathology report. Results: The severity of malnutrition risk is statistically significant in patients with vascular infiltration, pathological stage, age, albumin, tumor size, and BMI (p < 0.05). There was no statistically significant in terms of ethnicity, gender (p > 0.05). Based on the influencing factors identified by the above single factor screening, multi-factor logistic analysis was performed. 1. BMI is an independent protective factor for the severity of malnutrition risk in patients with gastric cancer, meaning that the higher the BMI, the lower the risk of malnutrition. 2. Plasma albumin is an independent protective factor for the severity of malnutrition risk. The higher the plasma albumin, the lower the risk of malnutrition. 3. The higher the age, the higher the severity of the risk of malnutrition. 4. Pathological staging is an independent factor influencing the degree of malnutrition risk. The higher the pathological stage, the higher the severity of the risk of malnutrition, which means that the pathological stage is an independent risk factor for the severity of the risk of malnutrition. 5. Vascular infiltration, tumor size are not the independent factors influencing the severity of malnutrition risk (p > 0.05). Conclusion: 1. Alb and BMI are independent protective factors for the severity of malnutrition risk. 2. Age is an independent risk factor for the severity of malnutrition risk. 3. The higher the pathological stage of gastric cancer patients, the more serious the risk of malnutrition.
文章引用:王昌利, 吴向华, 张江涛, 黄道来, 陈俊强, 贾葵, 陆利生, 张勇胜, 王献满. PG-SGA评分与胃癌患者病理分期的相关性研究[J]. 世界肿瘤研究, 2021, 11(2): 59-65. https://doi.org/10.12677/WJCR.2021.112008

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA—A Cancer Journal for Clinicians, 68, 394-424.
[Google Scholar] [CrossRef] [PubMed]
[2] 孙可欣, 郑荣寿, 张思维. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11.
[3] Mariette, C., De Botton, M.-L. and Piessen, G. (2012) Surgery in Esophageal and Gastric Cancer Patients: What Is the Role for Nutrition. Annals of Surgical Oncology, 19, 2128-2134.
[Google Scholar] [CrossRef] [PubMed]
[4] Harter, J., Orlandi, S. and Gonzalez, M. (2017) Nutritional and Functional Factors as Prognostic of Surgical Cancer Patients. Supportive Care in Cancer, 25, 2525-2530.
[Google Scholar] [CrossRef] [PubMed]
[5] 丁丽平, 张趁欣, 张爽. 消化系统恶性肿瘤患者营养状况及其影响因素分析[J]. 预防医学情报杂志, 2020, 36(9): 1228-1231+1237.
[6] 张艳华, 李晓玲, 李增宁. 国内恶性肿瘤患者营养不良影响因素Meta分析[J]. 中国临床保健杂志, 2020, 23(5): 649-655.
[7] 李晶, 赵化荣. 恶性肿瘤患者营养状况评估的研究进展[J]. 现代肿瘤医学, 2018, 26(1): 145-148.
[8] 吴国豪, 谈善军. 肿瘤患者营养支持指南[J]. 中华外科杂志, 2017, 55(11): 801-829.
[9] 石英英, 张晓伟, 袁凯涛, 等. PG-SGA操作标准介绍[J]. 中华肿瘤防治杂志, 2013, 20(22): 1779-1782.
[10] Mueller, C., Compher, C. and Ellen, D.M. (2011) A.S.P.E.N. Clinical Guidelines: Nutrition Screening, Assessment, and Intervention in Adults. Journal of Parenteral and Enteral Nutrition, 35, 16-24.
[Google Scholar] [CrossRef] [PubMed]
[11] 中国超重/肥胖医学营养治疗专家共识(2016年版) [J]. 中华糖尿病杂志, 2016, 8(9): 525-540.
[12] 陕飞, 李子禹, 张连海, 等. 国际抗癌联盟及美国肿瘤联合会胃癌TNM分期系统(第8版)简介及解读[J]. 中国实用外科杂志, 2017, 37(1): 15-17.
[13] Katai, H., Ishikawa, T., Akazawa, K., et al. (2017) Five-Year Survival Analysis of Surgically Resected Gastric Cancer Cases in Japan: A Retrospective Analysis of More than 100,000 Patients from the Nationwide Registry of the Japanese Gastric Cancer Association (2001-2007). Gastric Cancer, 21, 144-154.
[Google Scholar] [CrossRef] [PubMed]
[14] Bossola, M. (2015) Nutritional Interventions in Head and Neck Cancer Patients Undergoing. Nutrients, 7, 265-276.
[Google Scholar] [CrossRef] [PubMed]
[15] Steenhagen, E., et al. (2017) Nutrition in Peri-Operative Esophageal Cancer Management. Expert Review of Gastroenterology & Hepatology, 11, 663-672.
[Google Scholar] [CrossRef] [PubMed]
[16] Ryan, A.M., Power, D.G., Daly, L., et al. (2016) Cancer-Associated Malnutrition, Cachexia and Sarcopenia: The Skeleton in the Hospital Closet 40 Years Later. Proceedings of the Nutrition Society, 75, 199-211.
[Google Scholar] [CrossRef
[17] Segura, A., et al. (2005) An Epidemiological Evaluation of the Prevalence of Malnutrition in Spanish Patients with Locally Advanced or Metastatic Cancer. Clinical Nutrition, 24, 801-814.
[18] Laky, B., et al. (2008) Comparison of Different Nutritional Assessments and Body-Composition Measurements in Detecting Malnutrition among Gynecologic Cancer Patients. The American Journal of Clinical Nutrition, 87, 1678-1685.
[Google Scholar] [CrossRef] [PubMed]
[19] 恶性肿瘤患者的营养治疗专家共识[J]. 临床肿瘤学杂志, 2012, 17(1): 59-73.
[20] 王贺, 林欣, 康军, 等. 重庆某三甲医院不同分期肺癌住院患者营养风险与营养不良发生率横断面研究[J]. 中华临床营养杂志, 2018, 26(3): 162-169.
[21] 沈磊, 杨海涛, 杨春建. 合肥市属部分医疗机构消化道恶性肿瘤住院患者营养现状调查分析[J]. 现代肿瘤医学, 2020, 28(6): 980-983.
[22] Oñate-Ocaña, L.F., et al. (2007) Serum Albumin as a Significant Prognostic Factor for Patients with Gastric. Annals of Surgical Oncology, 14, 381-389.
[Google Scholar] [CrossRef] [PubMed]
[23] 王贤龙. 体质量指数与胃癌患者临床病理特征及预后的关系[J]. 临床医学研究与实践, 2021(3): 107-109.